Singapore publishes Summary Reports of Benefit-Risk Assessment for NCE/NBE online
Effective from June 2020 onward the Health Sciences Authority, Singapore will be publishing the Summary Reports of Benefit-Risk Assessments for …
Singapore launches new E-FORM for Therapeutic Products(TP)
Health Sciences Authority (HSA) Singapore launches a new online form to enable submission of post-approval documents/data of therapeutic products (TP) …
Singapore launches new e-form for post-approval Registration Conditions of Therapeutic Products
Health Sciences Authority (HSA) Singapore launches a new online form to enable submission of post-approval documents/data of therapeutic products (TP) …
Field Safety Corrective Action (FSCA) launched by HSA Singapore
Effective from 6 April 2020, the Health Science Authority(HSA ) of Singapore has launched the new OSCAR system for Field …
Singapore adds controls to certain mercury-added medical devices under EPMA
Singapore adds certain medical devices to the control list of Mercury-Added Products under the Environmental Protection and Management Act (“EPMA”). …
Singapore HSA released registration requirements on Next Generation Sequencing IVDs
Singapore, Health Sciences Authority (HSA) released the final document on Next Generation Sequencing NGS IVDs. This document focuses on the …